Combination Therapy With Copanlisib and ABL Tyrosine Kinase Inhibitors Against Philadelphia Chromosome-Positive Resistant Cells
Oncotarget - United States
doi 10.18632/oncotarget.10605
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 15, 2016
Authors
Publisher
Impact Journals, LLC